Catalent
CTLT
#1595
Rank
ยฃ8.43 B
Marketcap
ยฃ46.50
Share price
-0.35%
Change (1 day)
71.77%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

P/S ratio for Catalent (CTLT)

P/S ratio as of November 2024 (TTM): 2.45

According to Catalent's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.04. At the end of 2024 the company had a P/S ratio of 2.32.

P/S ratio history for Catalent from 2014 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20242.3217.29%
20231.9816.31%
20221.70-66.69%
20215.113.35%
20204.9563.79%
20193.0265.48%
20181.82-23.1%
20172.3733.8%
20161.774.41%
20151.70-9.11%
20141.87

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
3.31 35.04%๐Ÿ‡บ๐Ÿ‡ธ USA
3.52 43.49%๐Ÿ‡บ๐Ÿ‡ธ USA
1.98-19.54%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
2.50 1.90%๐Ÿ‡บ๐Ÿ‡ธ USA